Randomized equivalence study evaluating the possibility of switching hemodialysis patients receiving subcutaneous human erythropoietin directly to intravenous darbepoetin alfa. [electronic resource]
Producer: 20090707Description: 228-34 p. digitalISSN:- 1542-6270
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Anemia -- complications
- Darbepoetin alfa
- Erythropoietin -- administration & dosage
- Female
- Hemoglobins -- metabolism
- Humans
- Injections, Intravenous
- Injections, Subcutaneous
- Kidney Failure, Chronic -- complications
- Male
- Middle Aged
- Recombinant Proteins
- Renal Dialysis
- Therapeutic Equivalency
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.